Retinal damage can develop or worsen at any stage of pregnancy for women with diabetes, with no statistically significant differences in progression found across different trimesters, according to a recent retrospective study published in the Journal of Vitreoretinal Diseases and reported by diabetesincontrol.com.
Pregnancy accelerates diabetic eye disease for many patients, leaving clinicians to question whether a specific gestational stage carries higher risk than others. Researchers evaluated 158 women with diabetes using clinical data gathered before pregnancy, during each trimester, and after delivery to track retinal changes, as reported by diabetesincontrol.com.
Overall, 13 patients—representing 8.2% of the cohort—experienced worsening retinopathy during pregnancy. Observation periods showed varying progression rates, specifically 6.9% during the interval covering prepregnancy and the first trimester, 5.0% throughout the second trimester, and 14.3% during the third trimester. An additional 10.0% of patients experienced progression during the postpartum observation period.
Despite the higher third-trimester percentage, the comparison across trimesters produced a P value of .42, meaning the differences were not statistically significant. Among patients without retinopathy at baseline, new disease manifested in 4.62%, 7.69%, and 5.88% across the three pregnancy intervals, with a postpartum manifestation rate of 6.45% and a P value of .97.
Retinal damage can progress at any point during gestation
- No single danger trimester: Retinal damage can progress at any point during gestation, meaning doctors cannot rely on gestational timing alone to predict when eye damage will worsen.
- Baseline health matters most: The state of a patient’s retina before conception serves as a major predictor for whether diabetic eye disease will advance during pregnancy.
- Continuous care is required: Eye examinations should happen routinely throughout all of pregnancy and extend into the postpartum period rather than concentrating on one presumed high-risk window.
Why Baseline Retinal Health Outweighs Gestational Timing
While shifts in blood sugar, blood pressure, and circulation during pregnancy affect the retina, existing evidence highlights the critical importance of pre-conception retinal health. Women with existing retinal disease face a substantially greater risk of worsening compared to patients whose exams show no diabetic damage prior to pregnancy, according to diabetesincontrol.com.
Additional clinical factors influence retinal complications, including longer diabetes duration, elevated blood pressure, and suboptimal glucose management. Rapid improvements in blood glucose can also produce temporary worsening of existing retinopathy, particularly when patients intensify diabetes treatment before conception or during early pregnancy.
These physiological shifts do not discourage appropriate glucose management, as maintaining recommended targets remains essential for maternal and fetal health. Early identification of retinal abnormalities helps clinicians intervene before permanent vision loss occurs. Consequently, understanding baseline retinal status provides greater clinical value than relying solely on gestational timing.
Personalized Screening Protocols and Clinical Guidance
The findings support personalized eye care while maintaining current screening recommendations outlined in the American Diabetes Association’s 2026 Standards of Care. Before conception and throughout the first trimester, patients with preexisting type 1 or type 2 diabetes should undergo an eye exam; subsequent monitoring should occur every trimester and continue for up to one year postpartum, depending on how severe the retinopathy is.
Patients with moderate or worse nonproliferative retinopathy, proliferative retinopathy, or diabetic macular edema require prompt specialist assessment. Optical coherence tomography aids in evaluating suspected macular edema, while retinal photography supports documentation without replacing comprehensive eye examinations. Gestational diabetes alone generally does not increase short-term retinopathy risk enough to require pregnancy-specific retinal screening, though patients with previously diagnosed diabetes must follow established ophthalmic monitoring recommendations.
| Pregnancy Interval | Retinopathy Progression Rate | New Disease Appearance |
|---|---|---|
| Prepregnancy / First Trimester | 6.9% | 4.62% |
| Second Trimester | 5.0% | 7.69% |
| Third Trimester | 14.3% | 5.88% |
| Postpartum Period | 10.0% | 6.45% |
Seek urgent evaluation for sudden vision changes
Pregnant patients experiencing sudden blurred vision, new floaters, or abrupt vision loss must seek urgent ophthalmic evaluation. Treatment decisions require careful coordination among specialists, particularly regarding anti-vascular endothelial growth factor medications, which require caution due to potential fetal risks and limited safety data during pregnancy. Laser photocoagulation remains a viable option for certain vision-threatening conditions during gestation.
What Remains Unresolved in Retinal Progression
Although the retrospective study provides insight into retinal changes across gestation, authors note that the absence of statistical significance does not prove all trimesters carry identical risks. Because the project relied on a single-center retrospective design, these findings require confirmation in larger prospective populations to establish definitive risk timelines.
Broader global context underscores the urgency of these evaluations, as historical reviews note that India alone recorded approximately 43.9 million undiagnosed diabetes cases in 2019, with diabetic retinopathy posing substantial management challenges globally, according to a review published on PMC. As researchers continue investigating the hormonal, vascular, and metabolic drivers of retinal disease during gestation, the clinical priority remains individualized follow-up and coordinated multidisciplinary care.
Can pregnancy make diabetic retinopathy worse?
Can pregnancy make diabetic retinopathy worse?
Although not every patient experiences progression, pregnancy can exacerbate existing diabetic retinopathy, especially in cases involving long-term diabetes, suboptimal glucose control, or advanced baseline disease.
Which trimester carries the highest risk of retinopathy progression?
A 2026 retrospective study found no statistically significant difference in retinal progression across trimesters, though larger studies are needed to confirm whether trimester-related risk is truly equivalent.
How often should pregnant patients with diabetes receive retinal examinations?
Individuals diagnosed with type 1 or type 2 diabetes should have an eye assessment prior to pregnancy and during the first trimester, with follow-up screenings occurring in each subsequent trimester and lasting through the first year after delivery, based on the specific clinical findings.
Does improving blood glucose rapidly worsen diabetic retinopathy?
Rapid glucose improvement can temporarily worsen existing retinal disease in some patients, but appropriate glucose control remains essential, and closer retinal monitoring helps identify early changes.
Is retinal screening necessary for gestational diabetes?
Retinal screening specifically for pregnancy is generally not required for those with gestational diabetes alone, provided they do not have preexisting diabetes, which would otherwise necessitate adherence to standard ophthalmic monitoring protocols.
References
- Journal of Vitreoretinal Diseases, 2026 Retrospective Study on Diabetic Retinopathy in Pregnancy.
- PMC National Center for Biotechnology Information, Diabetic retinopathy in pregnancy – A review.
- British Journal of Ophthalmology, Clinical research in ophthalmology and vision science.
Disclaimer: This content is not medical advice. For any health issues, always consult a healthcare professional. In an emergency, call 911 or your local emergency services.
